HCV diagnostic testing US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for HCV diagnostic testing. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
HCV diagnostic testing US Medical PG Question 1: A scientist in Chicago is studying a new blood test to detect Ab to EBV with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity much greater than what she had originally hoped for. She travels to China to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with EBV. The scientist tests these 1,200 patients' blood and finds that only 120 of them tested negative with her new exam. Of the patients who are known to be EBV-free, only 20 of them tested positive. Given these results, which of the following correlates with the exam's specificity?
- A. 82%
- B. 90%
- C. 84%
- D. 86%
- E. 98% (Correct Answer)
HCV diagnostic testing Explanation: ***98%***
- **Specificity** measures the proportion of **true negatives** among all actual negatives.
- In this case, 800 patients are known to be EBV-free (actual negatives), and 20 of them tested positive (false positives). This means 800 - 20 = 780 tested negative (true negatives). Specificity = (780 / 800) * 100% = **98%**.
*82%*
- This value represents the *original sensitivity* before the scientist’s new attempts to improve the test.
- It does not reflect the *newly calculated specificity* based on the provided data.
*90%*
- This value represents the *newly calculated sensitivity* of the test, not the specificity.
- Out of 1200 EBV-infected patients, 120 tested negative (false negatives), meaning 1080 tested positive (true positives). Sensitivity = (1080 / 1200) * 100% = 90%.
*84%*
- This percentage is not directly derived from the information given for either sensitivity or specificity after the new test results.
- It does not correspond to any of the calculated values for the new test's performance.
*86%*
- This percentage is not directly derived from the information given for either sensitivity or specificity after the new test results.
- It does not correspond to any of the calculated values for the new test's performance.
HCV diagnostic testing US Medical PG Question 2: A 60-year-old rock musician presents to the office because he has been feeling increasingly tired for the past 6 months. He has a history of intravenous drug use and alcohol abuse. He states that he feels quite tired, but he otherwise has no complaints. Physical examination is noncontributory. His laboratory values are normal other than moderately elevated liver enzymes. Which of the following additional tests should you order first?
- A. Hepatitis C virus antibodies (Correct Answer)
- B. Hepatitis B surface antigen
- C. Hepatitis E virus-specific IgM antibodies
- D. Hepatitis D virus-specific IgG antibody
- E. Hepatitis A virus-specific IgM antibodies
HCV diagnostic testing Explanation: ***Hepatitis C virus antibodies***
- The patient's history of **intravenous drug use** and **chronic fatigue** with **elevated liver enzymes** strongly suggests chronic viral hepatitis, with hepatitis C being the most common blood-borne infection in persons with IVDU history.
- **Hepatitis C** is the **most prevalent chronic viral hepatitis** in the United States among persons with history of injection drug use, with transmission efficiency via needle sharing being very high.
- Hepatitis C often has a **long asymptomatic phase** (decades) before symptoms like fatigue and liver damage become apparent, making antibody testing the appropriate initial screen.
- While both HBV and HCV should ultimately be screened in this patient, **HCV prevalence is significantly higher** in the IVDU population, making it the priority initial test.
*Hepatitis B surface antigen*
- While **hepatitis B** can also be transmitted via intravenous drug use and cause chronic liver disease, **hepatitis C is more prevalent** in persons with IVDU history in the United States.
- **HBsAg** is used to detect active hepatitis B infection and should also be ordered, but given resource constraints and the clinical context, **anti-HCV is the higher-yield initial test**.
- Many IVDU patients have been vaccinated against HBV, further reducing its likelihood compared to HCV (for which no vaccine exists).
*Hepatitis E virus-specific IgM antibodies*
- **Hepatitis E** is typically transmitted via the **fecal-oral route** (contaminated water) and usually causes **acute, self-limiting hepatitis**, not chronic insidious fatigue and liver enzyme elevation in a Western patient.
- **IgM antibodies** would indicate an acute infection, which is less likely given the 6-month duration of symptoms.
- HEV rarely causes chronic infection except in immunocompromised patients.
*Hepatitis D virus-specific IgG antibody*
- **Hepatitis D** requires an existing **hepatitis B infection** to replicate (it's a satellite virus), meaning you would first need to confirm chronic hepatitis B before testing for HDV.
- While HDV can cause severe liver disease and is transmitted via blood exposure, it's not the initial test to pursue without evidence of HBV co-infection.
*Hepatitis A virus-specific IgM antibodies*
- **Hepatitis A** is transmitted via the **fecal-oral route** and causes an **acute, self-limiting infection** with complete resolution, rarely leading to chronic liver disease or persistent fatigue over 6 months.
- **IgM antibodies** are indicative of acute infection, which contradicts the chronic nature of the patient's symptoms.
- HAV does not cause chronic hepatitis.
HCV diagnostic testing US Medical PG Question 3: A 35-year-old male anesthesiologist presents to the occupational health clinic after a needlestick exposure while obtaining an arterial line in a patient with cirrhosis. In addition to a standard bloodborne pathogen laboratory panel sent for all needlestick exposures at his hospital, additional hepatitis panels are ordered upon the patient's request. The patient's results are shown below:
HIV 4th generation Ag/Ab: Negative/Negative
Hepatitis B surface antigen (HBsAg): Negative
Hepatitis C antibody: Negative
Anti-hepatitis B surface antibody (HBsAb): Positive
Anti-hepatitis B core IgM antibody (HBc IgM): Negative
Anti-hepatitis B core IgG antibody (HBc IgG): Positive
What is the most likely explanation of the results above?
- A. Window period
- B. Chronic infection
- C. Acute infection
- D. Immune due to infection (Correct Answer)
- E. Immune due to vaccination
HCV diagnostic testing Explanation: ***Immune due to infection***
- The presence of **anti-HBc IgG** along with **anti-HBsAb** in the absence of **HBsAg** indicates past resolution of HBV infection.
- This combination confers **natural immunity** following a prior exposure, distinguishing it from vaccine-induced immunity (which would lack anti-HBc IgG).
*Window period*
- This period is characterized by the absence of **HBsAg** and **anti-HBsAb**, with the only positive marker being **anti-HBc IgM**.
- The patient's results show positive **anti-HBsAb** and **anti-HBc IgG**, which rule out a window period.
*Chronic infection*
- Chronic infection is defined by the persistence of **HBsAg** for more than six months.
- The patient's **HBsAg is negative**, therefore excluding chronic infection.
*Acute infection*
- Acute infection would be evidenced by the presence of **HBsAg** and often **anti-HBc IgM**.
- Both **HBsAg** and **anti-HBc IgM** are negative in this patient, ruling out acute infection.
*Immune due to vaccination*
- Vaccination leads to the development of **anti-HBsAb** but does not produce **anti-HBc antibodies**.
- The presence of **anti-HBc IgG** in this patient indicates exposure to the complete virus, not just vaccination.
HCV diagnostic testing US Medical PG Question 4: A 60-year-old man comes to the physician’s office with jaundice. Liver ultrasound reveals a shrunken liver and biopsy reveals cirrhosis. Hepatitis serologies are below:
Anti-HAV: negative
HBsAg: negative
HBsAb: positive
HBeAg: negative
Anti-HBe: negative
Anti-HBc: negative
Anti-HCV: positive
The hepatitis C viral load is 1,000,000 copies/mL. The patient is started on an antiviral regimen including sofosbuvir. What is the mechanism of action of this drug?
- A. Inhibits reverse transcriptase
- B. Inhibits integrase
- C. Inhibits synthesis of DNA-dependent DNA polymerase
- D. Inhibits RNA-dependent RNA polymerase (Correct Answer)
- E. Inhibits hepatitis C protease
HCV diagnostic testing Explanation: ***Inhibits RNA-dependent RNA polymerase***
- Sofosbuvir is a **nucleotide analog** that targets the **HCV RNA-dependent RNA polymerase (NS5B)**, essential for viral replication.
- By inhibiting NS5B, it acts as a **chain terminator**, preventing the synthesis of new viral RNA strands.
*Inhibits reverse transcriptase*
- This mechanism is characteristic of drugs used to treat **HIV infection**, as reverse transcriptase is an enzyme found in retroviruses.
- Hepatitis C virus (HCV) is an **RNA virus** that replicates via an RNA intermediate, not DNA, and thus does not utilize reverse transcriptase.
*Inhibits integrase*
- Integrase inhibitors are a class of drugs primarily used in the treatment of **HIV infection**, preventing the viral DNA from integrating into the host genome.
- HCV replication does not involve an integration step into the host DNA, making this mechanism irrelevant for HCV treatment.
*Inhibits synthesis of DNA-dependent DNA polymerase*
- Inhibition of DNA-dependent DNA polymerase primarily targets organisms that replicate their DNA, such as **herpesviruses** or host cell processes.
- HCV is an RNA virus and does not synthesize or rely on a DNA-dependent DNA polymerase for its replication cycle.
*Inhibits hepatitis C protease*
- While **protease inhibitors (e.g., -previr drugs)** are an important class of anti-HCV drugs, sofosbuvir specifically targets the viral **RNA polymerase (NS5B)**.
- Protease inhibitors block the **NS3/4A protease**, which is responsible for cleaving the large HCV polyprotein into functional proteins.
HCV diagnostic testing US Medical PG Question 5: A 26-year-old woman who is a medical student is undergoing evaluation after sticking herself with a needle while drawing blood from a patient. The patient’s medical history is unknown. A blood sample from the medical student is drawn and processed, and the results are presented below:
Anti-HAV IgM negative
Anti-HAV IgG positive
HBsAg negative
HBeAg negative
Anti-HBs negative
Anti-HBc IgG negative
Anti-HBc IgM negative
Anti-HBe negative
Anti-HCV negative
What is true about the student’s laboratory findings?
- A. She has not been vaccinated against the hepatitis B virus. (Correct Answer)
- B. She recovered from a hepatitis B virus infection.
- C. She is infected with the hepatitis D virus.
- D. She can transmit the hepatitis A virus.
- E. She is an asymptomatic carrier of the hepatitis B virus.
HCV diagnostic testing Explanation: ***She has not been vaccinated against the hepatitis B virus.***
- A **negative Anti-HBs** indicates a lack of protective antibodies developed either through vaccination or past infection.
- A **negative Anti-HBc IgG** and **IgM** further confirms no prior exposure to the hepatitis B core antigen, which would be present with natural infection.
*She recovered from a hepatitis B virus infection.*
- Recovery from HBV infection would typically show **positive Anti-HBs** and **positive Anti-HBc IgG**, neither of which are present here.
- The absence of **Anti-HBc antibodies** rules out past natural infection, whether resolved or chronic.
*She is infected with the hepatitis D virus.*
- Hepatitis D virus (HDV) infection only occurs in the presence of an active **Hepatitis B virus (HBV) infection**.
- The student's **HBsAg negative** status indicates no active HBV infection, thereby ruling out HDV.
*She can transmit the hepatitis A virus.*
- **Anti-HAV IgG positive** indicates prior exposure to HAV or vaccination, leading to immunity.
- **Anti-HAV IgM negative** suggests no acute HAV infection, meaning she is not currently infectious.
*She is an asymptomatic carrier of the hepatitis B virus.*
- An asymptomatic carrier of HBV would have **positive HBsAg** and likely **positive Anti-HBc IgG**, but both are negative in this case.
- The absence of **HBsAg** definitively rules out an active carrier state.
HCV diagnostic testing US Medical PG Question 6: A 35-year-old man with no known past medical history presents to his physician because he is applying for a job as a healthcare worker, which requires screening for the hepatitis B virus (HBV). The patient states that he is in good health and denies any symptoms. His vital signs and physical exam are unremarkable. Labs are drawn, and the patient's HBV serology shows the following:
HBsAg: positive
anti-HBsAg antibody: negative
anti-HBcAg IgM: negative
anti-HBcAg IgG: positive
HBeAg: negative
anti-HBeAg antibody: positive
Which of the following best describes this patient's results?
- A. Immune due to previous infection
- B. Chronically infected, low infectivity (Correct Answer)
- C. Immune due to previous vaccination
- D. Acutely infected
- E. Chronically infected, high infectivity
HCV diagnostic testing Explanation: ***Chronically infected, low infectivity***
- The presence of **HBsAg positive** for more than 6 months indicates **chronic HBV infection**. The presence of **anti-HBeAg antibody** and **negative HBeAg** suggests **low viral replication activity** and thus low infectivity.
- **HBeAg negativity** along with positivity for **HBV DNA** (if tested, though not provided here) would further differentiate this state as **"HBeAg-negative chronic hepatitis B,"** which typically implies lower, but still present, infectivity compared to HBeAg-positive chronic infection.
*Immune due to previous infection*
- Immunity due to previous infection is characterized by **negative HBsAg** and **positive anti-HBsAg antibody**, along with **positive anti-HBcAg IgG**.
- This patient, however, is **HBsAg positive** and **anti-HBsAg antibody negative**, ruling out resolved infection.
*Immune due to previous vaccination*
- Immunity due to vaccination is characterized by **negative HBsAg**, **positive anti-HBsAg antibody**, and **negative anti-HBcAg antibody** (both IgM and IgG).
- This patient has **positive HBsAg** and **positive anti-HBcAg IgG**, indicating either current or past infection, not vaccination-induced immunity.
*Acutely infected*
- **Acute infection** is characterized by **positive HBsAg**, **negative anti-HBsAg antibody**, and typically **positive anti-HBcAg IgM**.
- This patient has **negative anti-HBcAg IgM**, which makes acute infection unlikely, as IgM antibodies are present early in acute infection.
*Chronically infected, high infectivity*
- **High infectivity** in chronic HBV infection is typically indicated by **positive HBsAg** and **positive HBeAg**, often with high levels of HBV DNA.
- This patient is **HBeAg negative** and **anti-HBeAg antibody positive**, indicating a lower level of viral replication and thus lower infectivity.
HCV diagnostic testing US Medical PG Question 7: An investigator is studying the rate of multiplication of hepatitis C virus in hepatocytes. The viral genomic material is isolated, enzymatically cleaved into smaller fragments and then separated on a formaldehyde agarose gel membrane. Targeted probes are then applied to the gel and visualized under x-ray. Which of the following is the most likely structure being identified by this test?
- A. Lipid-linked oligosaccharides
- B. Transcription factors
- C. Polypeptides
- D. Ribonucleic acids (Correct Answer)
- E. Deoxyribonucleic acids
HCV diagnostic testing Explanation: ***Ribonucleic acids***
- The description of isolating "viral genomic material," which is then "enzymatically cleaved" and run on a "formaldehyde agarose gel," followed by the application of "targeted probes" and X-ray visualization, perfectly matches the technique of **Northern blotting**.
- Northern blotting is used to detect and quantify specific **RNA sequences**, which is consistent with the hepatitis C virus being an RNA virus.
*Lipid-linked oligosaccharides*
- These molecules are involved in protein glycosylation and are typically analyzed using techniques like **mass spectrometry** or **chromatography**, not Northern blotting.
- They are not nucleic acid material, which is implied by "viral genomic material" and enzymatic cleavage steps.
*Transcription factors*
- **Transcription factors** are proteins that regulate gene expression and would typically be identified using techniques like **Western blotting** (for protein detection) or Electrophoretic Mobility Shift Assay (EMSA) for DNA binding.
- They are not directly "genomic material" that would be cleaved and run on an agarose gel in this manner.
*Polypeptides*
- **Polypeptides** are chains of amino acids, i.e., proteins, which are normally detected using **Western blotting** after separation on an SDS-PAGE gel.
- The use of "formaldehyde agarose gel" and "enzymatic cleavage" points specifically to nucleic acid analysis, not protein analysis.
*Deoxyribonucleic acids*
- While DNA is genomic material and is often analyzed similarly, the use of a **formaldehyde agarose gel** is characteristic of RNA electrophoresis because formaldehyde prevents RNA from forming secondary structures.
- Furthermore, hepatitis C is a **single-stranded RNA virus**, meaning its genome is RNA, not DNA.
HCV diagnostic testing US Medical PG Question 8: A 57-year-old man comes to the physician because of generalized malaise, yellowish discoloration of the eyes, and pruritus on the back of his hands that worsens when exposed to sunlight for the past several months. He has not seen a physician in 15 years. Physical examination shows scleral icterus and mild jaundice. There is a purpuric rash with several small vesicles and hyperpigmented lesions on the dorsum of both hands. The causal pathogen of this patient's underlying condition was most likely acquired in which of the following ways?
- A. Ingestion of raw shellfish
- B. Inhalation of spores
- C. Needlestick injury (Correct Answer)
- D. Bathing in freshwater
- E. Sexual contact
HCV diagnostic testing Explanation: ***Needlestick injury***
- The jaundice, scleral icterus, pruritus, and **purpuric rash worsened by sunlight** (suggesting **Porphyria Cutanea Tarda**) are highly indicative of **chronic Hepatitis C virus infection**.
- **Hepatitis C** is primarily transmitted through **blood-to-blood contact**, with **needlestick injuries** and intravenous drug use being the most common routes.
*Ingestion of raw shellfish*
- **Hepatitis A virus** and **Vibrio vulnificus** can be acquired this way, but they typically cause acute, self-limiting illness or severe sepsis, respectively, not chronic liver disease with porphyria.
- **Hepatitis A** does not lead to chronic hepatitis or the dermatological manifestations described.
*Inhalation of spores*
- **Inhalation of spores** is associated with fungal infections like **histoplasmosis** or **coccidioidomycosis**, which do not typically cause chronic hepatitis, jaundice, pruritus, or porphyria cutanea tarda.
- These infections primarily affect the lungs, though disseminated forms can occur, they do not match the presented symptoms.
*Bathing in freshwater*
- **Bathing in freshwater** can transmit pathogens like **Leptospira** or **Schistosoma**, causing leptospirosis or schistosomiasis, respectively.
- These infections present with different clinical pictures and are not associated with chronic hepatitis, jaundice, or porphyria cutanea tarda.
*Sexual contact*
- While **Hepatitis C** can be transmitted sexually, this route is significantly **less efficient** than blood-to-blood contact.
- **Hepatitis B** is more commonly associated with sexual transmission and can also cause chronic liver disease, but the presence of **Porphyria Cutanea Tarda** is a characteristic extrahepatic manifestation strongly associated with **chronic Hepatitis C infection**.
- Given the clinical presentation, **needlestick injury or intravenous drug use** (blood-borne transmission) is the most likely route of HCV acquisition.
HCV diagnostic testing US Medical PG Question 9: A group of researchers conducted various studies on hepatitis C incidence and prevalence. They noticed that there is a high prevalence of hepatitis C in third-world countries, where it has a significant impact on the quality of life of the infected individual. The research group made several attempts to produce a vaccine that prevents hepatitis C infection but all attempts failed. Which of the following would most likely be the reason for the failure to produce a vaccine?
- A. Non-DNA genome
- B. Tolerance
- C. Antigenic mimicry
- D. Polysaccharide envelope
- E. Antigenic variation (Correct Answer)
HCV diagnostic testing Explanation: ***Antigenic variation***
- The **hepatitis C virus (HCV)** undergoes rapid **antigenic variation**, particularly in its envelope glycoproteins, which allows it to evade the host immune system.
- This high mutation rate presents a significant challenge for vaccine development, as a vaccine designed against one viral strain may not be effective against others.
*Non-DNA genome*
- While HCV is an **RNA virus** (non-DNA genome), this characteristic alone does not inherently prevent vaccine development; many effective RNA virus vaccines exist (e.g., measles, mumps).
- The type of genome is less critical than its stability and the virus's ability to mutate rapidly.
*Tolerance*
- **Immune tolerance** occurs when the immune system fails to respond to an antigen, often due to chronic exposure. While relevant in chronic HCV infection, it's not the primary reason for vaccine failure.
- The goal of a vaccine is to induce an effective immune response before tolerance can set in.
*Antigenic mimicry*
- **Antigenic mimicry** involves a pathogen's antigens resembling host antigens, potentially leading to autoimmune responses or immune evasion.
- While it can be a factor in some chronic infections, the rapid, diverse changes in HCV's surface antigens are a more prominent obstacle to vaccine design.
*Polysaccharide envelope*
- HCV is an **enveloped virus**, but its envelope is composed of **lipoproteins** with viral glycoproteins, not a polysaccharide capsule.
- Polysaccharide capsules are a feature of some bacteria (e.g., Streptococcus pneumoniae) and fungi, and while they can pose vaccine challenges, they are not relevant to HCV.
HCV diagnostic testing US Medical PG Question 10: A 13-year-old boy presents to the pediatrician with yellow discoloration of the sclerae since yesterday, and dark-colored urine for 2 days. A detailed history is taken and reveals that he had a cough, cold, and fever the week before the onset of the current symptoms, and was treated with over-the-counter medications. He reports an improvement in his upper respiratory symptoms but has been experiencing fatigue, nausea, and poor appetite since then. There is no past history of recurrent nausea, vomiting, jaundice or abdominal pain, and he has not received any blood transfusion. In addition, he frequently eats at a roadside restaurant near his school. His growth and development are normal for his age and sex. The temperature is 37.9°C (100.2°F), pulse is 96/min, blood pressure is 110/70 mm Hg, and the respiratory rate is 22/min. The physical examination shows icterus. The examination of the abdomen reveals tender hepatomegaly with the liver having a firm, sharp, and smooth edge. The laboratory test results are as follows:
Hemoglobin 14.2 g/dL
WBC (white blood cell) 10,500/mm3
Differential leukocyte count
Segmented neutrophils 56%
Bands 4%
Lymphocytes 35%
Eosinophils 2%
Basophils 0%
Monocytes 3%
Platelet count 270,000/mm3
Serum total bilirubin 8.4 mg/dL
Serum direct bilirubin 7.8 mg/dL
Serum alanine aminotransferase 350 U/L
Serum alkaline phosphatase 95 U/L
Prothrombin time 20 seconds
Which of the following laboratory tests is most likely used to diagnose the condition of this patient?
- A. Plasma tyrosine and methionine
- B. Serum anti-HAV IgM antibody (Correct Answer)
- C. Quantitative assay for glucose-6-phosphate dehydrogenase (G6PD) activity
- D. Urine for reducing substances
- E. Percutaneous liver biopsy
HCV diagnostic testing Explanation: ***Serum anti-HAV IgM antibody***
- The patient's symptoms (jaundice, dark urine, fatigue, nausea, tender hepatomegaly) following an upper respiratory illness, especially with a history of eating at a roadside restaurant, are highly suggestive of **acute hepatitis A infection**.
- **IgM antibodies** to hepatitis A virus (HAV) are detectable early in the course of infection and indicate **acute or recent infection**, making it the most appropriate diagnostic test.
*Plasma tyrosine and methionine*
- These tests are used in the diagnosis of **tyrosinemia**, a rare inherited metabolic disorder that can cause liver failure.
- The patient's acute presentation and history of potential exposure to HAV make tyrosinemia less likely, and **elevated transaminases** are not specific to tyrosinemia.
*Quantitative assay for glucose-6-phosphate dehydrogenase (G6PD) activity*
- This assay is used to diagnose **G6PD deficiency**, an inherited condition that can cause hemolytic anemia, particularly after exposure to certain drugs or foods, which might lead to jaundice from unconjugated hyperbilirubinemia.
- However, the patient's presentation with **tender hepatomegaly**, conjugated hyperbilirubinemia (direct bilirubin significantly elevated), and elevated transaminases is more consistent with **hepatocellular injury** rather than hemolysis.
*Urine for reducing substances*
- This test is used to screen for **galactosemia** or other disorders of carbohydrate metabolism in infants and young children, where undigested sugars appear in the urine.
- It is not indicated for the diagnosis of acute hepatitis in an adolescent with the presented clinical picture.
*Percutaneous liver biopsy*
- While a liver biopsy can provide definitive information about liver pathology, it is an **invasive procedure** and is generally not the initial diagnostic test for acute viral hepatitis due to its risks.
- **Serological markers** for viral hepatitis are less invasive and usually sufficient for diagnosing acute hepatitis A.
More HCV diagnostic testing US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
